Scientech Research »

Enliven Therapeutics shares owned by Scientech Research

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Scientech Research from 13F filings

Historical chart of Scientech Research investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Scientech Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Scientech Research

Quarter filed Position value Share count Share price at filing
2026-03-31 $620k 16k 39.20

More positions owned by Scientech Research

Applied Digital Corp Com New (APLD)
Wave Life Sciences SHS (WVE)
Echostar Corp Cl A (SATS)
Themes Etf Tr Leverage Shs 2x (CRCG)
Scholar Rock Hldg Corp (SRRK)
Miragen Therapeutics (VRDN)
Figma Class A Com Stk (FIG)
Century Aluminum Company (CENX)
Oklo Com Cl A (OKLO)
Coinbase Global Com Cl A (COIN)
Five Below (FIVE)
Cytomx Therapeutics (CTMX)
Graniteshares Etf Tr 2x Long Coin Dai (CONL)
Snowflake Com Shs (SNOW)
Planet Labs Pbc Com Cl A (PL)

View all positions for Scientech Research

Top funds holding Enliven Therapeutics

OrbiMed Advisors
FMR
BlackRock
Polar Capital Holdings
Commodore Capital
Vestal Point Capital
Vanguard Group
Citadel Advisors
Fairmount Funds Management
VR Adviser
Novo A/S
Geode Capital Management
State Street Corporation
Logos Global Management
Pictet Asset Management Holding SA

View all funds holding Enliven Therapeutics